TABLE 1.
Clinical and pathologic characteristics of patients with gastric cancer
| Characteristics | Total (n = 376) | Early stage* (n = 155) | Late stage** (n = 221) |
|---|---|---|---|
| Age at operation, median (IQR) | 65.7 (54.7–74.2) | 67.5 (54.4–75.3) | 65.3 (54.9–73.6) |
| Sex, number (%) | |||
| Female | 169 (45) | 66 (43) | 103 (47) |
| Male | 207 (55) | 89 (57) | 118 (53) |
| Preoperative weight (kg), mean | 74.3 | 76.6 | 72.7 |
| Preoperative BMI, mean | 27.1 | 27.4 | 26.9 |
| BMI < 30 kg/m2, number (%) | 279 (74) | 111 (72) | 168 (76) |
| BMI ≥ 30 kg/m2, number (%) | 97 (26) | 44 (28) | 53 (24) |
| Race/ethnicity, number (%) | |||
| White, non-Hispanic | 243 (65) | 106 (68) | 137 (62) |
| Black, non-Hispanic | 30 (8) | 12 (8) | 18 (8) |
| Hispanic | 32 (9) | 11 (7) | 21 (10) |
| Asian | 60 (16) | 22 (14) | 38 (17) |
| Other/unknown | 11 (3) | 4 (3) | 7 (3) |
| Postoperative pathologic stage, number (%) | |||
| 0 | 16 (4) | 16 (10) | 0 (0) |
| I | 153 (41) | 139 (90) | 14 (6) |
| II | 121 (32) | 0 (0) | 121 (55) |
| III | 82 (22) | 0 (0) | 82 (37) |
| IV | 4 (1) | 0 (0) | 4 (2) |
| Type of operation, number (%) | |||
| Subtotal/BII | 142 (38) | 60 (39) | 82 (37) |
| Subtotal/RY | 92 (24) | 40 (26) | 52 (24) |
| Total/RY | 142 (38) | 55 (35) | 87 (39) |
| Major complication (≥Grade 3), number (%) | 54 (14) | 20 (13) | 34 (15) |
| Neoadjuvant chemotherapy, number (%) | 150 (40) | 42 (27) | 108 (49) |
| Adjuvant chemotherapy, number (%) | 132 (35) | 23 (15) | 109 (49) |
| Postoperative feeding tube, number (%) | 20 (5) | 6 (4) | 14 (6) |
| Median follow-up, months (IQR) | 25.8 (13.4–42.1) | 26.4 (13–45.1) | 25 (13.9–40.1) |
*
Early stage = T1/T2, N0
**
Late stage = T3/T4, N0 and Any T, N1–3;
BMI body mass index, BII Billroth-II, RY Roux-en-Y